Last Updated: May 3, 2026

Details for New Drug Application (NDA): 022320

✉ Email this page to a colleague

NDA 022320 describes EPIDUO, which is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug and two Paragraph IV challenges. Additional details are available on the EPIDUO profile page.

The generic ingredient in EPIDUO is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for 022320

Tradename:	EPIDUO
Applicant:	Galderma Labs Lp
Ingredient:	adapalene; benzoyl peroxide
Patents:	3

Pharmacology for NDA: 022320

Suppliers and Packaging for NDA: 022320

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320	NDA	Galderma Laboratories, L.P.	0299-5908	0299-5908-00	1 TUBE in 1 BLISTER PACK (0299-5908-00) / 2 g in 1 TUBE
EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320	NDA	Galderma Laboratories, L.P.	0299-5908	0299-5908-02	2 g in 1 TUBE (0299-5908-02)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	0.1%;2.5%
Approval Date:	Dec 8, 2008	TE:	AB	RLD:	Yes
Patent:	8,071,644	Patent Expiration:	Jul 18, 2027	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF ACNE
Patent:	8,080,537	Patent Expiration:	Jul 18, 2027	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF ACNE
Patent:	8,129,362	Patent Expiration:	Jul 18, 2027	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF ACNE

Expired US Patents for NDA 022320

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	8,241,649	⤷ Start Trial
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	7,964,202	⤷ Start Trial
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	4,717,720	⤷ Start Trial
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	8,105,618	⤷ Start Trial
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	8,809,305	⤷ Start Trial
Galderma Labs Lp	EPIDUO	adapalene; benzoyl peroxide	GEL;TOPICAL	022320-001	Dec 8, 2008	8,936,800	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.